Lv1
90 积分 2023-05-04 加入
Interleukin-5 and Interleukin-5 Receptor Polymorphism in Asthma
2天前
已关闭
Comparison of tucidinostat with CHOP-like versus CHOP-like in first-line treatment of peripheral T-cell lymphoma: a single-center real-world study
4个月前
已完结
Prophylactic therapy using epigenetic agents for RUNX1::RUNXT1-positive high-risk AML after Allo-HSCT
9个月前
已完结
Inotuzumab ozogamicin versus standard of care in Asian patients with relapsed/refractory acute lymphoblastic leukemia
1年前
已完结
Inotuzumab ozogamicin，an anti ‐ CD22 ‐ calecheamicin conjugate，for refractory and relapsed acute lymphocytic leukaemia:a phase 2 study
1年前
已完结
Flow cytometric study of potential target antigens (CD19， CD20， CD22， CD33) for antibody ‐ based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases
1年前
已完结
Participation in breast cancer risk counseling among women with a family history
1年前
已关闭
Participation in breast cancer risk counseling among women with a family history
1年前
已关闭
Updates in the Management of Relapsed and Refractory Acute Lymphoblastic Leukemia: An Urgent Plea for New Treatments Is Being Answered!
1年前
已完结
Case report: Treatment of long COVID with a SARS-CoV-2 antiviral and IL-6 blockade in a patient with rheumatoid arthritis and SARS-CoV-2 antigen persistence
1年前
已完结
皖公网安备34019202002308
